| scholarly article | Q13442814 |
| P50 | author | Edward L. Giovannucci | Q20740896 |
| Meir J. Stampfer | Q80164992 | ||
| P2093 | author name string | June M Chan | |
| Stacey A Kenfield | |||
| Preet K Dhillon | |||
| P2860 | cites work | Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis | Q24796323 |
| Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis | Q28166676 | ||
| A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence | Q28182821 | ||
| Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study | Q28218423 | ||
| A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence | Q28222395 | ||
| Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers | Q33561179 | ||
| The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. | Q33735295 | ||
| Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials | Q34263106 | ||
| Risk factors for prostate cancer incidence and progression in the health professionals follow-up study | Q34621511 | ||
| The TNM classification of prostate cancer | Q36060490 | ||
| Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006. | Q36241844 | ||
| Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy | Q36510749 | ||
| Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation | Q37086749 | ||
| Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement | Q37467382 | ||
| Reproducibility and Validity of an Expanded Self-Administered Semiquantitative Food Frequency Questionnaire among Male Health Professionals | Q39605930 | ||
| A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor | Q43550236 | ||
| A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. | Q43688021 | ||
| A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. | Q46011552 | ||
| Aspirin and hormone therapy for prostate cancer | Q46832158 | ||
| Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients. | Q51825306 | ||
| Test of the National Death Index | Q71344931 | ||
| Identification of bone marrow micrometastases in patients with prostate cancer | Q71649303 | ||
| Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy | Q83143261 | ||
| P433 | issue | 10 | |
| P921 | main subject | aspirin | Q18216 |
| prostate cancer | Q181257 | ||
| cancer diagnosis | Q110324059 | ||
| P304 | page(s) | 1223-1228 | |
| P577 | publication date | 2012-09-07 | |
| P1433 | published in | Cancer Prevention Research | Q2665103 |
| P1476 | title | Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort | |
| P478 | volume | 5 |
| Q90167160 | A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer |
| Q54117069 | Arterial Thrombosis in Patients with Cancer. |
| Q64078727 | Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis |
| Q46176546 | Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men. |
| Q26751511 | Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies |
| Q36267681 | Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy |
| Q26827455 | Can Aspirin and Cancer Prevention be Ageless Companions? |
| Q44264785 | Cancer and Thrombotic Risk: The Platelet Paradigm |
| Q38918805 | Common medications and prostate cancer mortality: a review |
| Q38226775 | Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature |
| Q28081491 | Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies |
| Q40200492 | Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts |
| Q37650468 | Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy? |
| Q33614082 | Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis |
| Q54484100 | Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink. |
| Q36989392 | Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer |
| Q57111350 | Regular aspirin use and gene expression profiles in prostate cancer patients |
| Q41670120 | Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial |
Search more.